Invion Ltd. (IVIXF)
OTHER OTC:IVIXF
Holding IVIXF?
Track your performance easily

Invion Ltd. (IVIXF) Stock Price & Analysis

11 Followers

IVIXF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

8.51%91.49%
― Other Institutional Investors
91.49% Public Companies and
Individual Investors

IVIXF FAQ

What was Invion Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Invion Ltd.’s market cap?
Currently, no data Available
When is Invion Ltd.’s upcoming earnings report date?
Invion Ltd.’s upcoming earnings report date is Mar 04, 2025 which is in 121 days.
    How were Invion Ltd.’s earnings last quarter?
    Invion Ltd. released its earnings results on Aug 30, 2024. The company reported >-$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-$0.001.
      Is Invion Ltd. overvalued?
      According to Wall Street analysts Invion Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Invion Ltd. pay dividends?
        Invion Ltd. does not currently pay dividends.
        What is Invion Ltd.’s EPS estimate?
        Invion Ltd.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Invion Ltd. have?
        Invion Ltd. has 6,816,592,000 shares outstanding.
          What happened to Invion Ltd.’s price movement after its last earnings report?
          Invion Ltd. reported an EPS of >-$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of Invion Ltd.?
            Currently, no hedge funds are holding shares in IVIXF
            ---

            Invion Ltd. Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            -33.81%
            Trailing 12-Months
            Asset Growth
            -18.61%
            Trailing 12-Months

            Company Description

            Invion Ltd.

            Invion Ltd a clinical-stage drug development company, develops treatments for cancer. It develops a novel PhotoDynamic Therapy (PDT) for cancer. The company has produced a topical and intravenous product suitable for use in skin cancer and in solid tumours, such as ovarian, prostate and lung cancer.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Advaxis
            Anixa Biosciences
            VolitionRX
            Bioxcel Therapeutics
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis